Catalyst Pharma's total assets for Q3 2025 were $1.05B, an increase of 8.20% from the previous quarter. DE:CN2 total liabilities were $131.36M for the fiscal quarter, a 13.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.